[HTML][HTML] Physical stability and dissolution of lumefantrine amorphous solid dispersions produced by spray anti-solvent precipitation

SV Bhujbal, V Pathak, DY Zemlyanov, LS Taylor… - Journal of …, 2021 - Elsevier
This study aims to develop amorphous solid dispersion (ASD) of lumefantrine with a cost-
effective approach of spray anti-solvent precipitation. Four acidic polymers …

[HTML][HTML] Physical stability and release properties of lumefantrine amorphous solid dispersion granules prepared by a simple solvent evaporation approach

NS Trasi, SV Bhujbal, DY Zemlyanov, QT Zhou… - International Journal of …, 2020 - Elsevier
Amorphous solid dispersions (ASDs) of lumefantrine, which has low aqueous solubility,
have been shown to improve bioavailability relative to crystalline formulations. Herein, the …

Balancing solid-state stability and dissolution performance of lumefantrine amorphous solid dispersions: the role of polymer choice and drug–polymer interactions

TN Hiew, DY Zemlyanov, LS Taylor - Molecular pharmaceutics, 2021 - ACS Publications
Amorphous solid dispersions (ASDs) are of great interest due to their ability to enhance the
delivery of poorly soluble drugs. Recent studies have shown that, in addition to acting as a …

[HTML][HTML] Combining drug salt formation with amorphous solid dispersions–a double edged sword

TN Hiew, LS Taylor - Journal of Controlled Release, 2022 - Elsevier
Glass transition temperature (T g) is important for amorphous compounds because it can
have implications on their physical and chemical stability. With drugs that possess ionizable …

Acid-base interactions in amorphous solid dispersions of lumefantrine prepared by spray-drying and hot-melt extrusion using X-ray photoelectron spectroscopy

Y Song, D Zemlyanov, X Chen, Z Su, H Nie… - International journal of …, 2016 - Elsevier
This study investigates drug-excipient interactions in amorphous solid dispersions (ASDs) of
the model basic compound lumefantrine (LMN), with five acidic polymers. X-ray …

Amorphous drug–polymer salt with high stability under tropical conditions and fast dissolution: the challenging case of lumefantrine-PAA

X Yao, S Kim, Y Gui, Z Chen, J Yu, KJ Jones… - Journal of Pharmaceutical …, 2021 - Elsevier
Abstract Lumefantrine (LMF), a high-mobility and easy-to-crystallize WHO drug for treating
malaria, can form an amorphous salt with poly (acrylic acid)(PAA) that is remarkably stable …

Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation

R Fule, T Meer, A Sav, P Amin - Journal of pharmaceutical investigation, 2013 - Springer
The interest in hot-melt extrusion as a drug delivery technology for the production of solid
dispersion is growing rapidly. Lumefantrine (LUMF) is an antimalarial drug that exhibits poor …

Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance

R Fule, D Dhamecha, M Maniruzzaman, A Khale… - International journal of …, 2015 - Elsevier
The aim of this study was to investigate the industrial feasibility of developing a co-
formulated solid dispersion (SD) containing two antimalarial drugs artemether (ARTM) and …

Alginate as a potential diphase solid dispersion carrier with enhanced drug dissolution and improved storage stability

J Guan, Q Liu, X Zhang, Y Zhang, R Chokshi… - European Journal of …, 2018 - Elsevier
The objective of this study was to explore the feasibility of using alginate as a promising
diphase solid dispersion carrier to enhance dissolution rate of BCS II drugs with improved …

Amorphous solid dispersion of nisoldipine by solvent evaporation technique: Preparation, characterization, in vitro, in vivo evaluation, and scale up feasibility study

RB Chavan, A Lodagekar, B Yadav… - Drug delivery and …, 2020 - Springer
The present study was designed to determine the applicability of a newly derived
dimensionless number precipitation parameter,“supersaturation holding capacity (SHC)” in …